Evidence map›Paper›PMID 36835173›Full record

ReviewInternational journal of molecular sciences2023

Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse.

Emma Lindell, Lei Zhong, Xiaonan Zhang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. A workflow for quantifying cell quiescence in 3D spheroids.Biochemistry and biophysics reports · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Mitochondrial Metabolism and Dynamics in Cancer Cells.Cancer treatment and research · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Dynamic sensor selection for biomarker discovery.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emma LindellDepartment of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Lei ZhongDepartment of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Xiaonan ZhangDepartment of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-4359-9079
Uppsala University · SE

Funding

Barncancerfonden PR2020-0079Barncancerfonden TJ 2021-0111Göran Gustafsson 2022Jeansson Foundations 2021
6 · The paper itself

Abstract

Quiescent cancer cells (QCCs) are nonproliferating cells arrested in the G0 phase, characterized by ki67

Indexed as

Neoplasm Recurrence, LocalResting Phase, Cell CycleCell CycleCell DivisionHumansRecurrencedrug resistancenovel therapeutic strategiesquiescenttumor recurrence

Identifiers

PMID36835173
PMCPMC9959385
OpenAlexW4320731194

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.